tiprankstipranks
BriaCell Therapeutics Corp (TSE:BCT)
TSX:BCT
Canadian Market

BriaCell Therapeutics (BCT) Income Statement

Compare
65 Followers

BriaCell Therapeutics Income Statement

Last quarter (Q1 2025), BriaCell Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, BriaCell Therapeutics's net income was C$-5.80M. See BriaCell Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -20.49KC$ -19.39KC$ -19.44KC$ -18.74KC$ -18.74K
Operating Expenses
C$ 23.27MC$ -3.39KC$ -3.69M--
Depreciation and Amortization
C$ 15.27KC$ 19.39KC$ 19.44KC$ 18.74KC$ 18.74K
EBITDA
C$ -27.22MC$ -34.05MC$ -17.49MC$ -4.89MC$ -5.74M
Operating Income
C$ -23.27MC$ -15.29MC$ 3.69MC$ 1.38MC$ 946.42K
Other Income/Expenses
C$ 2.97MC$ -18.78MC$ -6.84MC$ -85.10KC$ 905.30K
Pretax Income
C$ -20.30MC$ -11.55MC$ 3.69MC$ 1.38MC$ 946.42K
Net Income
C$ -20.30MC$ -11.58MC$ -2.89MC$ 1.38MC$ 602.68K
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -1.74C$ -0.75C$ -0.19C$ 1.94C$ 1.04
Diluted EPS
C$ -1.74C$ -0.75C$ -0.19C$ 1.94C$ 1.04
Weighted Average Shares Outstanding
15.62M 15.49M 15.27M 713.89K 579.66K
Weighted Average Shares Outstanding (Diluted)
15.62M 15.52M 15.27M 713.89K 579.66K
Currency in CAD

BriaCell Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis